India’s daily cases now third highest in world

NEW DELHI: For the fourth consecutive day, more than 40,000 fresh cases were reported in the country and the steady increase in cases has once again pushed India to become the world’s third-worst affected country in terms of daily cases.

Data compiled by the WHO shows that once again the trio of Brazil, the US and India are leading the world in daily cases. WHO data shows that on March 22, Brazil had reported 79,069 new cases, the highest in the world, followed by the US at 60,228 and India at 46,951. Analysis of daily case data for the past few days shows that India reached the third spot on March 19 and since then it has maintained that position.

India reported 40,622 fresh cases on Monday, with data from Assam yet to arrive till late at night. An analysis of state-wise data shows that the increase in cases was no longer confined to a few states. Despite being a Monday, when cases dip every week, at least nine states reported their highest case count since January or earlier.

Gujarat, for instance, reported 1,640 cases on Monday, the highest ever in the state. Similarly, Monday saw the highest cases this year for Chhattisgarh (1,525), MP (1,348), Delhi (888) and Himachal (200). Tamil Nadu also reported 1,385 cases on Monday, the highest since December 14. Rajasthan reported 602 cases, the highest since January 1. Similarly, UP and Odisha too reported the highest cases since January 10 and January 24, respectively.

So many peaks at the state level suggests that it is highly likely there is a pan-India resurgence of cases.

Deaths too were increasing and the daily toll breached the 200 mark on Sunday.

  • Related Posts

    Licences of 20 medical stores suspended after inspections

    Drug Control Department inspects 120 medical stores; 32 NDPS cases and 63 arrests recorded in 2026 so far The district administration has intensified action against illegal drug sale and distribution,…

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    NEW DELHI: Global investment firm Bain Capital has divested nearly a 1 per cent stake in Emcure Pharmaceuticals for over Rs 289 crore through open market transactions, according to the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Licences of 20 medical stores suspended after inspections

    Licences of 20 medical stores suspended after inspections

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    HP accounts for 47 inferior drugs in March alert

    HP accounts for 47 inferior drugs in March alert

    Civil society group SAM calls for greater transparency involving clinical trials

    Civil society group SAM calls for greater transparency involving clinical trials

    Different packaging, typos expose fake Mounjaro racket

    Different packaging, typos expose fake Mounjaro racket